MEDICLINIC INTERNATIONAL LIMITED - Dealings in securities by directors of the company and by the company secretary and a director of a major subsidiary

Dealings in securities by directors of the company and by the company secretary and a director of a major subsidiary

Mediclinic International Limited
(Incorporated in the Republic of South Africa)
(Registration number: 1983/010725/06)
ISIN: ZAE000074142
JSE Share Code: MDC
NSX Share Code: MCI
("Mediclinic" or “the Company”)

DEALINGS IN SECURITIES BY DIRECTORS OF THE COMPANY AND BY THE
COMPANY SECRETARY AND A DIRECTOR OF A MAJOR SUBSIDIARY

In compliance with the Listings Requirements of the JSE Limited
(“JSE”), the following information is disclosed relating to the
sale of ordinary shares in Mediclinic by directors of the Company
and a major subsidiary:

Director                     :   Mr D P Meintjes
Company                      :   Mediclinic International Limited
Date of transaction          :   13 February 2015
Nature of transaction        :   On market sale of securities
Class of securities          :   Ordinary shares
Number of securities         :   25 000
Selling price                :   VWAP: R126.8992 per share
                                 Lowest price: R124.76 per share
                                 Highest price: R129.50 per share
Total value of transaction   :   R3 172 480.00
Nature of interest           :   Direct beneficial

Director                     :   Mr C I Tingle
Company                      :   Mediclinic International Limited
Date of transaction          :   13 February 2015
Nature of transaction        :   On market sale of securities
Class of securities          :   Ordinary shares
Number of securities         :   25 000
Selling price                :   VWAP: R126.8992 per share
                                 Lowest price: R124.76 per share
                                 Highest price: R129.50 per share
Total value of transaction   :   R3 172 480.00
Nature of interest           :   Direct beneficial

Director                     :   Mr G C Hattingh (Company
                                 Secretary)
Company                      :   Mediclinic International Limited
Date of transaction          :   13 February 2015
Nature of transaction        :   On market sale of securities
Class of securities          :   Ordinary shares
Number of securities         :   5 000
Selling price                :   3 250 at R127.80 per share
                                 1 750 at R127.81 per share
Total value of transaction   :   R639 017.50
Nature of interest           :   Indirect beneficial

Director                     :   Ms L Heerink-Smit (Company
                                 Secretary)
Company                      :   Mediclinic Investments (Pty) Ltd
                                 (major subsidiary of Mediclinic
                                 International Limited)
Date of transaction          :   13 February 2015
Nature of transaction        :   On market sale of securities
Class of securities          :   Ordinary shares
Number of securities         :   2 374
Selling price                :   R128.00 per share
Total value of transaction   :   R303 872.00
Nature of interest           :   Direct beneficial

Clearance was obtained for these transactions as required by the
JSE Listings Requirements.

Stellenbosch
16 February 2015

Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa
PO Box 456, Stellenbosch 7599, South Africa
Tel +27 (0)21 809 6500
Fax +27 (0)21 886 4037
Ethics Line: 0800 005 316
Website: www.mediclinic.com

JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank
Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

Date: 16/02/2015 10:34:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.